Cardiovascular Risk in Toledo Population (RICARTO)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03294369|
Recruitment Status : Recruiting
First Posted : September 27, 2017
Last Update Posted : January 29, 2020
|Condition or disease||Intervention/treatment|
|Cardiovascular Risk Factor Cardiovascular Diseases||Other: Observational|
Epidemiological and observational study that is analyzing a sample from the general population aged 18 years or older, randomly selected from a database of sanitary cards stratified by age and gender.
Clinical history, physical examination and complementary tests are being performed.
Total blood and serum samples are being frozen (-85ºC) for future genetic studies. The biobank is currently being registered at the "Virgen de la Salud" hospital of Toledo.
CVR is assessed by SCORE scale calibrated for Spanish population and the Framingham Heart Study scale.
Patients will be periodically visited, with a minimum follow-up of 5 years. Standard statistical analysis will be performed.
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||3125 participants|
|Target Follow-Up Duration:||5 Years|
|Official Title:||RIesgo CARdiovascular y Eventos Cardiovasculares en la población General Del área Sanitaria de TOledo|
|Actual Study Start Date :||April 1, 2011|
|Estimated Primary Completion Date :||December 31, 2020|
|Estimated Study Completion Date :||December 31, 2020|
Cohort of the study
A sample from the general population aged 18 years or older, randomly selected from a database of sanitary cards stratified by age and gender.
This is an observational study. No specific diagnostic or therapeutic procedure will be performed due to the study.
- Assess cardiovascular risk of the study population [ Time Frame: December 2020 ]Cardiovascular risk will be determined according to SCORE scale calibrated for Spanish population and the Framingham Heart Study scale.
- Prevalence of cardiovascular risk factors [ Time Frame: December 2020 ]To assess the prevalence of cardiovascular risk factors
- Prevalence of cardiovascular disease [ Time Frame: December 2020 ]To assess the prevalence of cardiovascular disease
Biospecimen Retention: Samples With DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03294369
|Contact: Gustavo C Rodriguez-Roca, MD, PhDfirstname.lastname@example.org|
|Avenida de Irlanda, 12, 2º A||Recruiting|
|Toledo, Spain, 45005|
|Contact: Gustavo C Rodriguez-Roca, MD, PhD 608293478 email@example.com|
|Sub-Investigator: Francisco J Alonso-Moreno, MD, PhD|
|Sub-Investigator: Alejandro Villarin-Castro, MD|
|Sub-Investigator: Antonio Segura-Fragoso, MD, PhD|
|Sub-Investigator: Luis Rodriguez-Padial, MD, PhD|
|Sub-Investigator: Juan Fernandez-Martin, MD, PhD|
|Sub-Investigator: Carlos Escobar-Cervantes, MD, PhD|